DE69940927D1 - PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT - Google Patents

PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT

Info

Publication number
DE69940927D1
DE69940927D1 DE69940927T DE69940927T DE69940927D1 DE 69940927 D1 DE69940927 D1 DE 69940927D1 DE 69940927 T DE69940927 T DE 69940927T DE 69940927 T DE69940927 T DE 69940927T DE 69940927 D1 DE69940927 D1 DE 69940927D1
Authority
DE
Germany
Prior art keywords
peptide fragments
amino acid
series
cell death
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940927T
Other languages
English (en)
Inventor
Masaki Hirashima
Hiroaki Maeda
Chikateru Nozaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Application granted granted Critical
Publication of DE69940927D1 publication Critical patent/DE69940927D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE69940927T 1998-11-19 1999-11-12 PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT Expired - Lifetime DE69940927D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34786398 1998-11-19
PCT/JP1999/006322 WO2000031131A1 (fr) 1998-11-19 1999-11-12 Fragments peptidiques a activite inhibitrice de la mort cellulaire

Publications (1)

Publication Number Publication Date
DE69940927D1 true DE69940927D1 (de) 2009-07-09

Family

ID=18393115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940927T Expired - Lifetime DE69940927D1 (de) 1998-11-19 1999-11-12 PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT

Country Status (8)

Country Link
US (2) US7199097B1 (de)
EP (1) EP1132402B1 (de)
JP (1) JP4485062B2 (de)
AT (1) ATE432287T1 (de)
AU (1) AU1179500A (de)
CA (1) CA2351558C (de)
DE (1) DE69940927D1 (de)
WO (1) WO2000031131A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002067976A1 (fr) * 2001-02-28 2002-09-06 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Nouveaux inhibiteurs de lesion d'ischemie/reperfusion
JPWO2002076493A1 (ja) * 2001-03-23 2004-10-14 財団法人化学及血清療法研究所 新規な免疫異常性疾患予防・治療用薬剤
JPWO2002076492A1 (ja) * 2001-03-23 2004-07-15 財団法人化学及血清療法研究所 新規な運動障害改善剤
JP4402885B2 (ja) * 2001-05-11 2010-01-20 財団法人化学及血清療法研究所 新規な神経変性疾患治療剤
US7960508B2 (en) 2001-05-11 2011-06-14 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Peptide having cytotoxicity inhibitory activity and method of screening these peptide having cytotoxicity inhibitory activity
DE60232876D1 (de) * 2001-05-16 2009-08-20 Xavier Forceville Verfahren für die in-vitro-diagnostik oder für die überwachung einer krankheit mit entzündungsreaktion
JP2003026598A (ja) * 2001-06-27 2003-01-29 Chemo Sero Therapeut Res Inst 新規なリウマチ予防・治療用薬剤
EP1418182A4 (de) * 2001-08-09 2004-11-17 Juridical Foundation Verfahren zur herstellung von peptidfragmenten mit zelltodhemmender wirkung
JP2004182616A (ja) * 2002-11-29 2004-07-02 Chemo Sero Therapeut Res Inst 新規な神経伝達機能異常疾患改善剤
WO2008122039A2 (en) 2007-04-02 2008-10-09 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Selenocysteine mediated hybrid antibody molecules
JP6370637B2 (ja) * 2013-08-27 2018-08-08 学校法人同志社 ２型糖尿病の治療及び／又は予防薬
CN114907445B (zh) * 2022-05-10 2023-06-06 华南农业大学 一种高抗氧化活性富硒肽及其应用

Also Published As

Publication number Publication date
US20050281808A1 (en) 2005-12-22
JP4485062B2 (ja) 2010-06-16
EP1132402B1 (de) 2009-05-27
WO2000031131A1 (fr) 2000-06-02
AU1179500A (en) 2000-06-13
US7598349B2 (en) 2009-10-06
EP1132402A4 (de) 2005-12-21
EP1132402A1 (de) 2001-09-12
CA2351558A1 (en) 2000-06-02
ATE432287T1 (de) 2009-06-15
CA2351558C (en) 2010-01-12
US7199097B1 (en) 2007-04-03

Similar Documents

Publication Publication Date Title
ATE368053T1 (de) Antimikrobielle peptide
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
DK150992A (da) Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
ATE247173T1 (de) Charakterisierung von polypeptiden
ATE295414T1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
ATE269902T1 (de) Cytokinähnliches polypeptid-10 aus säugetieren
DE69940927D1 (de) PEPTIDFRAGMENTE MIT DEN ZELLTOD VERHINDERNDEr AKTIVITÄT
KR960704934A (ko) 항혈전활성을 갖는 펩티드 및 이의 제조방법(Peptide having antithrombotic activity and process for producing the same)
DK156592A (da) Human-h1-praeprorelaxin, -prorelaxin og -relaxin samt polypeptid med relaxinaktivitet og fremgangsmaade til sammenfoejning af a- og b-kaederne i human-h1-relaxin
DE69840509D1 (de) Apoptose-bezogene verbindungen und deren verwendung
KR950700934A (ko) 미엘린 염기성 단백질의 펩타이드 단편을 이용하여 t세포의 증식을 억제하는 방법
ATE362939T1 (de) Dimere von thrombinpeptidderivaten
DE69840024D1 (de) Antimikrobielle Peptide, abstammend von Ubiquicidin
DE69607034T2 (de) Pcna bindende substanz
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
ATE374246T1 (de) Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter
TR200003498T2 (tr) Amino asit sekansından oluşan bir polipetit, bunun aşıları ve kullanımları
DE60234843D1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid
ATE328897T1 (de) Verwendung von hev-polypeptiden
DK1158050T3 (da) Human cysteinyl-leukotrienreceptor (CysLT2)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R079 Amendment of ipc main class

Ref document number: 1132402

Country of ref document: EP

Free format text: PREVIOUS MAIN CLASS: C07K0014470000

Ipc: C07K0014435000